Healthcare | May 09, 2022
Strengthening the access to rare disease treatment in India
Takeda and United Nations Global Compact Network of India (UNGCNI) join hands
Takeda and United Nations Global Compact Network of India (UNGCNI) join hands
If granted, Nuvaxovid would be the first protein-based Covid-19 vaccine option for adolescents in Australia and New Zealand
The department will soon release a policy to catalyze research & development and innovation in the pharma- Medtech sector in India
The research was funded by the National Institutes of Health, the Eversight Center for Vision and Eye Banking Research, and Research to Prevent Blindness
This agreement is truly remarkable for achieving greater objectives in the projects and addressing larger problems
The report has estimated 4.74 million deaths for India in 2020 and 2021,
Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication
The facility is among 12 centres established worldwide, and the first in Asia
Three RFPs now open for qualified researchers through NORD's Jayne Holtzer rare disease research grants program
As an industrial partner of the IHU, the Medi-Globe Group is thus further expanding its role as an innovation leader in minimally invasive diagnostics and therapies
Subscribe To Our Newsletter & Stay Updated
